The Phenotype-Based Approach Can Solve Cold Cases: The Paradigm of Mosaic Mutations of the CREBBP Gene
Author:
Marchetti Giulia Bruna1, Milani Donatella2ORCID, Pisciotta Livia13ORCID, Pezzoli Laura4ORCID, Marchisio Paola12, Rinaldi Berardo5ORCID, Iascone Maria4ORCID
Affiliation:
1. Università degli Studi di Milano Statale, 20122 Milano, Italy 2. Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico di Milano, 20122 Milano, Italy 3. Child Neuropsychiatry Unit, ASST Fatebenefratelli Sacco, 20100 Milano, Italy 4. Laboratorio di Genetica Medica, ASST Papa Giovanni XXIII, 24127 Bergamo, Italy 5. Medical Genetics Unit, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, 20122 Milano, Italy
Abstract
Rubinstein–Taybi syndrome (RTS) is a rare genetic disorder characterized by intellectual disability, facial dysmorphisms, and enlarged thumbs and halluces. Approximately 55% of RTS cases result from pathogenic variants in the CREBBP gene, with an additional 8% linked to the EP300 gene. Given the close relationship between these two genes and their involvement in epigenomic modulation, RTS is grouped into chromatinopathies. The extensive clinical heterogeneity observed in RTS, coupled with the growing number of disorders involving the epigenetic machinery, poses a challenge to a phenotype-based diagnostic approach for these conditions. Here, we describe the first case of a patient clinically diagnosed with RTS with a CREBBP truncating variant in mosaic form. We also review previously described cases of mosaicism in CREBBP and apply clinical diagnostic guidelines to these patients, confirming the good specificity of the consensus. Nonetheless, these reports raise questions about the potential underdiagnosis of milder cases of RTS. The application of a targeted phenotype-based approach, coupled with high-depth NGS, may enhance the diagnostic yield of whole-exome sequencing (WES) in mild and mosaic conditions.
Reference27 articles.
1. Adam, M.P., Feldman, J., Mirzaa, G.M., Pagon, R.A., Wallace, S.E., Bean, L.J.H., Gripp, K.W., and Amemiya, A. (2024, May 01). Rubinstein-Taybi Syndrome. 30 August 2002 [Updated 9 November 2023], GeneReviews®, Available online: https://www.ncbi.nlm.nih.gov/books/NBK1526/. 2. Lacombe, D., Bloch-Zupan, A., Bredrup, C., Cooper, E.B., Houge, S.D., García-Miñaúr, S., Kayserili, H., Larizza, L., Gonzalez, V.L., and A Menke, L. (2024). Diagnosis and management in Rubinstein-Taybi syndrome: First international consensus statement. J. Med. Genet. 3. Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP;Petrif;Nature,1995 4. Genetic heterogeneity in Rubinstein-Taybi syndrome: Mutations in both the CBP and EP300 genes cause disease;Roelfsema;Am. J. Hum. Genet.,2005 5. Mendelian disorders of the epigenetic machinery: Postnatal malleability and therapeutic prospects;Fahrner;Hum. Mol. Genet.,2019
|
|